Abstract:Aim To investigate the correlation between clinicopathological features and risk stratification in cervical cancer patients, and evaluate the feasibility of tumor-infiltrating immune cells as prognostic biomarkers in clinical practice. Methods CD3+ tumor infiltrating T cells (TILs), CD45RO+ TILs, CD4+ TILs, CD8+ TILs, FOXP3+ TILs (regulatory T cells, Tregs), CD68+ tumor associated macrophages (TAMs), CD163+ TAMs, and PD-L1+ tumor cells were immunostained in formalin-fixed paraffin-embedded (PPFE) tissues from 96 cervical cancer patients. Immunostaining density and other clinicopathological features such as age, FIGO stage, histopathologic type, Ki67 index, HPV status, lymhovasular invasion status (LVI), lymph node metastasis, tumor size, stromal invasion status, surgical margin status, and parametrial invasion, were evaluated for their roles in risk stratification of cervical cancer patients. Results The results showed that significant differences of lymph node metastasis ( p = 0.003), surgical margin status ( p = 0.020), and stromal invasion status ( p = 0.004) existed between lVI(−) and LVI(+) patients. CD3+ TILs in the central tumor area ( p = 0.010), CD4+ TILs in the central tumor area ( p = 0.045), CD8 + TILs in the central tumor area ( p = 0.033), and CD8+ TILs in the invasive margin area ( p = 0.004) showed significant differences between lVI(−) and LVI(+) patients. When patients were grouped by status of lymph node metastasis, significant differences of FIGO stage ( p = 0.005), LVI status ( p = 0.003), CD3+ TILs in the central tumor area ( p = 0.045), CD45RO+ TILs in the central tumor area ( p = 0.033), and CD45RO+ TILs in the invasive margin area ( p = 0.028) were also observed. After the patients were stratified into low-, intermediate-, and high risk groups, significant differences of FIGO stage ( p = 0.018), status of lymph node metastasis ( p = 0.000), LVI status ( p = 0.000), parametrial invasion status (p=0.012), stromal invasion status ( p = 0.000), tumor growth pattern ( p = 0.015) and tumor size ( p = 0.000) were identified among 3 groups of patients, while only CD45RO+ TILs in the invasive margin area ( p = 0.018) and FOXP3+ TILs in the central tumor area ( p = 0.009) were statistically different among three groups of patients. Spearman’s correlation analysis demonstrated that FIGO stage, LVI status, status of lymph node metastasis, parametrial invasion, stromal invasion status, and tumor size positively correlated with risk stratification ( P = 0.005, 0.020, 0.000, 0.022, 0.000, and 0.000 respectively), while CD45RO+ TILs in the invasive margin area and FOXP3+ TILs in the central tumor area showed statistically negative correlation with risk stratification ( P = 0.031, 0.009 respectively). Conclusion Our study suggested that CD45RO+ TILs in the invasive margin area and FOXP3+ TILs in the central tumor area might be useful biomarkers for risk stratification in cervical cancer patients. Large cohort studies of cervical cancer patients are required to validate our hypothesis.

Expressions of Immune Negative Regulator FoxP3+Treg and PD-L1 Protein in the Immune Microenvironment of Cervical Lesion.

The investigation of regulatory role of immune factors FoxP3,CCL22 and CCR4 in the mi-croenvironment of cervical cancer

Aberrant Expressions of Immune Factors Facilitate the Disequilibrium of Immune Status in Cervical Cancer

Negative immune factors might predominate local tumor immune status and promote carcinogenesis in cervical carcinoma

The expression of 53 in cervical carcinoma

Elevated Expression of Programmed Death-1 and Programmed Death Ligand-1 Negatively Regulates Immune Response Against Cervical Cancer Cells

Relationship and prognostic significance of IL‐33, PD‐1/PD‐L1, and tertiary lymphoid structures in cervical cancer

Expression and Clinical Significance of Programmed Death-1 on Lymphocytes and Programmed Death Ligand-1 on Monocytes in the Peripheral Blood of Patients with Cervical Cancer

Expression of Interleukin - 10,E26 Transformation Factor - 1 and Tumor - Associated Macrophages in Cervical Cancer

The Expression of TGFβ1 in Cervical Carcinoma

[Assay of S-100+ Langerhans Cells in Cervical Carcinoma].

Expression and Clinicopathological Significance of Foxp3 and VISTA in Cervical Cancer.

Expression of Immune Cell Markers and Tumor Markers in Patients with Cervical Cancer.

Enhanced expression of PD L1 in cervical intraepithelial neoplasia and cervical cancers

Correlation of expression of IDO and FoxP3 with progression and prognosis of cervical cancer

Expression and clinical significance of HER-2 oncogene in cervical lesion cells

A reversed CD4/CD8 ratio of tumor-infiltrating lymphocytes and a high percentage of CD4 + FOXP3 + regulatory T cells are significantly associated with clinical outcome in squamous cell carcinoma of the cervix

Expressions and Related Studies of Survivin and OPN in Different Cervical Lesions

Expression and Clinical Significance of Nuclear Factor kappa B p65 and Tumor Necrosis Factor α in Cervical Carcinogenesis

Relationship between PD-L1 expression and regulatory T cell infiltration in lung cancer tis-sues and their clinical significance

Correlation between subsets of tumor-infiltrating immune cells and risk stratification in patients with cervical cancer